Doctors may soon detect cancerous cells in real-time during endoscopies, thanks to a collaboration between Optiscan Imaging Ltd and Monash University.
The project will develop an advanced gastrointestinal (GI) endomicroscope equipped with artificial intelligence (AI). This miniature digital microscope, designed to fit standard endoscopes, will capture subcellular-level images. Powered by AI, the system will automatically identify abnormal cells, enabling immediate medical intervention.
Associate Professor Zongyuan Ge from Monash’s AIM for Health Lab explained that this innovation could cut cancer screening times, boost early treatment success, and improve patient outcomes.
Supported by an Australian CRC-P grant, the project highlights the synergy between research and industry. Optiscan CEO Dr. Camile Farah called the partnership a major step forward in diagnosing and treating GI diseases.Monash’s researchers will work with Optiscan’s partners, including the University Medical Center Mainz in Germany, to bring this cutting-edge technology closer to reality. Read more about this topic at agewellaustralia.au